Literature DB >> 34410915

Antibiotics and COPD: Time to order a C-reactive protein test?

Cleveland Piggott1, Corey Lyon1.   

Abstract

This RCT provided valuable insights as to whether CRP-guided prescribing could safely reduce antibiotic use during acute COPD exacerbations.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34410915      PMCID： PMC8407218          DOI： 10.12788/jfp.0202

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  8 in total

1.  Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections.

Authors:  Jennifer L Schroeck; Christine A Ruh; John A Sellick; Michael C Ott; Arun Mattappallil; Kari A Mergenhagen
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions.

Authors:  H J Prins; Ruud Duijkers; Paul van der Valk; Marianne Schoorl; Johannes M A Daniels; Tjip S van der Werf; Wim G Boersma
Journal:  Eur Respir J       Date:  2019-05-23       Impact factor: 16.671

3.  C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.

Authors:  Christopher C Butler; David Gillespie; Patrick White; Janine Bates; Rachel Lowe; Emma Thomas-Jones; Mandy Wootton; Kerenza Hood; Rhiannon Phillips; Hasse Melbye; Carl Llor; Jochen W L Cals; Gurudutt Naik; Nigel Kirby; Micaela Gal; Evgenia Riga; Nick A Francis
Journal:  N Engl J Med       Date:  2019-07-11       Impact factor: 91.245

4.  Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Authors:  Jadwiga A Wedzicha; Marc Miravitlles; John R Hurst; Peter M A Calverley; Richard K Albert; Antonio Anzueto; Gerard J Criner; Alberto Papi; Klaus F Rabe; David Rigau; Pawel Sliwinski; Thomy Tonia; Jørgen Vestbo; Kevin C Wilson; Jerry A Krishnan
Journal:  Eur Respir J       Date:  2017-03-15       Impact factor: 16.671

Review 5.  Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

Authors:  J M Singh; V A Palda; M B Stanbrook; K R Chapman
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

6.  International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

Authors:  A Sonia Buist; Mary Ann McBurnie; William M Vollmer; Suzanne Gillespie; Peter Burney; David M Mannino; Ana M B Menezes; Sean D Sullivan; Todd A Lee; Kevin B Weiss; Robert L Jensen; Guy B Marks; Amund Gulsvik; Ewa Nizankowska-Mogilnicka
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

7.  C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.

Authors:  Chunhong Peng; Chan Tian; Yonggang Zhang; Xiaodong Yang; Yulin Feng; Hong Fan
Journal:  Am J Med Sci       Date:  2013-03       Impact factor: 2.378

8.  Cost-effectiveness of point-of-care C-reactive protein tests for respiratory tract infection in primary care in England.

Authors:  Rachael Hunter
Journal:  Adv Ther       Date:  2015-01-27       Impact factor: 3.845
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.